Axonics Modulation Technologies

Axonics is a pre-revenue company developing novel implantable neuromodulation technology licensed from The Alfred Mann Foundation directed toward a number of clinical indications, including the treatment of chronic pain and overactive bladder.

Axonics Modulation Technologies Company Profile

Founded in The United States around 2012, Axonics Modulation Technologies produces invasive hardware.

Axonics Modulation Technologies makes tools for medical diagnosis and treatment through body/mind state interpretation and/or neurostimulation therapies.

BCI Categories: Open-Loop Afferent

Neurostimulation Technique(s): PNS

FDA

Axonics Modulation Technologies has 123 medical devices registered with the FDA. Here are some of them:

Examples of FDA Approved Devices ( View List)

Device ID	Device Name	Class	Category	PMA	PMN
P180046	Stimulator, Electrical, Implantable, For Incontinence	3	Gastroenterology, Urology	True	False
P190006	Implanted Electrical Device Intended For Treatment Of Fecal Incontinence	3	Gastroenterology, Urology	True	False
P180046	Stimulator, Electrical, Implantable, For Incontinence	3	Gastroenterology, Urology	True	False
P180046	Stimulator, Electrical, Implantable, For Incontinence	3	Gastroenterology, Urology	True	False
P190006	Implanted Electrical Device Intended For Treatment Of Fecal Incontinence	3	Gastroenterology, Urology	True	False

Hardware

• BrainScope

Links

Website Crunchbase LinkedIn FacebookInstagram YouTube Twitter